• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EXALT MODEL D SINGLE USE DUODENOSCOPE - CLINICAL; DUODENOSCOPE AND ACCESSORIES, FLEXIBLE/RIGID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EXALT MODEL D SINGLE USE DUODENOSCOPE - CLINICAL; DUODENOSCOPE AND ACCESSORIES, FLEXIBLE/RIGID Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Dehydration (1807); Fever (1858); High Blood Pressure/ Hypertension (1908); Pancreatitis (4481)
Event Date 09/14/2022
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that an exalt model d single use duodenoscope was used during an endoscopic retrograde cholangiopancreatography (ercp) on a 77-year-old female patient ((b)(6)), enrolled in the exalt d scope 02 study on (b)(6) 2022.The procedure was successfully completed and there were no device malfunctions reported.The patient was subsequently diagnosed with acute pancreatitis with on onset date of (b)(6) 2022.The patient was hospitalized from (b)(6) 2022 and treated with fluids and pain medication.The severity of the pancreatitis was reported to be mild.The principal investigator (pi) assessed the pancreatitis as having a causal relationship to the ercp and a possible relationship to the exalt model d scope.
 
Manufacturer Narrative
The complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.(report source): e7156 exalt dscope 02 clinical study.(b)(4).
 
Manufacturer Narrative
Block h6: the following patient codes were added based on additional information: e2326,e230101,e1201,e1002,e2320.Block b5, b6: based on additional information the patient presented additional symptoms and had a culture test which came out negative.Block d4, h4: the complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.Block g2 (report source): e7156 exalt dscope 02 clinical study.Block h6 (patient codes): patient code e1021 captures the reportable event of pancreatitis requiring hospitalization.
 
Event Description
It was reported to boston scientific corporation that an exalt model d single use duodenoscope was used during an endoscopic retrograde cholangiopancreatography (ercp) on a 77-year-old female patient (b)(6) , enrolled in the exalt d scope 02 study on september 14, 2022.The procedure was successfully completed and there were no device malfunctions reported.The patient was subsequently diagnosed with acute pancreatitis with on onset date of (b)(6) 2022.The patient was hospitalized from (b)(6) 2022 and treated with fluids and pain medication.The severity of the pancreatitis was reported to be mild.The principal investigator (pi) assessed the pancreatitis as having a causal relationship to the ercp and a possible relationship to the exalt model d scope.Additional information received on november 30, 2022.A biopsy of pancreatic head mass was performed during the ecrp on (b)(6) 2022.The patient was diagnosed with adenocarcinoma.The patient presented to the emergency department on (b)(6) 2022 with progressive epigastric abdominal pain, low grade fevers, elevated blood pressure, and dehydration, subsequently the patient was diagnosed with acute pancreatitis, with an onset date of (b)(6) 2022.Ct of the abdomen showed new fat stranding around pancreatic head, pancreaticoduodenal groove and adjacent to the proximal duodenum extending into the region of the gallbladder fossa suggests either worsening acute pancreatitis and/or duodenitis.The patient was hospitalized from (b)(6) 2022 and treated with fluids and pain medication.The patients blood pressure was elevated while in the hospital and they received hydralazine as needed.The severity of the pancreatitis was reported to be mild.The patient was discharged home on (b)(6) 2022 in stable condition.The patient was instructed to follow up with oncology and have resection after pancreatitis clears fully.The principal investigator (pi) reassessed the pancreatitis as having a causal relationship to the ercp and as not related to the exalt model d scope.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXALT MODEL D SINGLE USE DUODENOSCOPE - CLINICAL
Type of Device
DUODENOSCOPE AND ACCESSORIES, FLEXIBLE/RIGID
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
2546 calle primera
alajuela
CS  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key15822816
MDR Text Key303899614
Report Number3005099803-2022-06527
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K193202
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/27/2022
Initial Date FDA Received11/18/2022
Supplement Dates Manufacturer Received11/30/2022
Supplement Dates FDA Received12/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization;
Patient Age77 YR
Patient SexFemale
-
-